
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial*
Ahmann, Andrew J., Capehorn, Matthew, Charpentier, Guillaume, Dotta, Francesco, Henkel, Elena, Lingvay, Ildiko, Holst, Anders G., Annett, Miriam P., Aroda, Vanita R.Langue:
english
Journal:
Diabetes Care
DOI:
10.2337/dc17-0417
Date:
December, 2017
Fichier:
PDF, 798 KB
english, 2017